<DOC>
	<DOCNO>NCT02931708</DOCNO>
	<brief_summary>Heart failure incapacity provide adequate blood flow others organ , brain , liver kidney . The patient present weakness fatigue inspiratory muscle , mainly diaphragm muscle , contribute dyspnoea limited physical capacity patient . Some method study decrease diaphragm weakness . The diaphragm functional eletrical stimulation new technique , study improve respiratory muscle strength . Then , aim study assess effect diaphragm functional electrical stimulation ( FES ) respiratory muscle strength muscle architecture patient heart failure . For follow assessment perform stimulation : manovacuometry verify maximum inspiratory pressure maximum expiratory pressure ; ultrasonography ass muscle architecture . The subject select decompensation heart failure , adequate elegibility criterion . This study control group , technique little research could unethical patient wo n't receive treatment . The subjetcs research receive diaphragm functional electrical stimulation twice day consecutive five day hospital discharge . Expected result end protocol Diaphragm Functional Electrical Stimulation : improve respiratory muscle strength ; correlate diaphragm muscle arquiteture .</brief_summary>
	<brief_title>Diaphragmatic Functional Electrical Stimulation Heart Failure</brief_title>
	<detailed_description>The research develop São Francisco Hospital , Santa Casa de Misericordia de Porto Alegre . After selection patient eligibility criterion evaluate , subsequently patient trained twice day five day hospital discharge . Will use electric current call functional electrical stimulation stimulator device NEURODYN II , IBRAMED mark , Amparo , São Paulo , Brazil . Each session last 30 minute . The parameter select stimulator : 80 Hz frequency , 0.4 m pulse , rise 1 , 1 time , decay 2 , 1 time , intensity patient tolerance . The patient position supine , headboard 30º , knee extend . Furthermore , electrode use perform electrical stimulation adhesive , disposable hypoallergenic . These place sixth , seventh eighth intercostal space , axiliar medium line paraxiphoid chest side . At end follow-up , compare data intervention .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients heart failure , admit hospital decompensation disease Cognitive impairment prevents conduct evaluation , well inability understand sign inform consent form ; Epidermal lesion site application and/or intolerance stimulator and/or skin sensitivity change ; Use pacemaker , cardiac resynchronization and/or implantable cardioverter defibrillator ; Body mass index &gt; 40Kg/m²</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Diaphragm</keyword>
	<keyword>Electrical Stimulation</keyword>
</DOC>